PRTA announced that BMS communicated that the FDA granted Fast Track Designation to BMS-986446, an anti-tau antibody in P2 for Alzheimer's disease.

Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of diseaseFast Track Designation recognizes the potential of ...

In this context, conductive foam serves as a key "electromagnetic pathway" connecting the battery module casing and the ...

U.S. Customs and Border Protection officials detected cesium 137 in shipping containers of shrimp sent by PT Bahari Makmur Sejati to several U.S. ports. CBP officials flagged the potential ...

Drug prices in the UK could rise amid 100 per cent tariffs on branded medicines, and pressure from US President Donald Trump ...

President Donald Trump is putting import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities ...

Squibb, 95, wasn’t the lead of a movie until she was 94. Now, a year after she turned action star in “Thelma,” Squibb is ...

At 95 years old, June Squibb continues to be an actress of tremendous charm, although her irresistibility is put to the test ...

Bristol Myers Squibb (NYSE: BMY) will announce results for the third quarter of 2025 on Thursday, October 30, 2025. Company executives will review financial results with the investment community ...

News Channel 11’s John Jenco and Terry Craig discussed an exciting Bass Pro Shops Night Race at the Bristol Motor Speedway (BMS) over the weekend. Christopher Bell managed his ...

Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum ...